[go: up one dir, main page]

ZA200508341B - Agents for the treatment of lower abdominal disorders - Google Patents

Agents for the treatment of lower abdominal disorders

Info

Publication number
ZA200508341B
ZA200508341B ZA200508341A ZA200508341A ZA200508341B ZA 200508341 B ZA200508341 B ZA 200508341B ZA 200508341 A ZA200508341 A ZA 200508341A ZA 200508341 A ZA200508341 A ZA 200508341A ZA 200508341 B ZA200508341 B ZA 200508341B
Authority
ZA
South Africa
Prior art keywords
agents
treatment
lower abdominal
abdominal disorders
disorders
Prior art date
Application number
ZA200508341A
Inventor
Gebauer Ursula
Simon Wolfgang-Alexander
Velten Iris
Original Assignee
Altana Pharmaag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharmaag filed Critical Altana Pharmaag
Publication of ZA200508341B publication Critical patent/ZA200508341B/en

Links

ZA200508341A 2003-05-06 2005-10-14 Agents for the treatment of lower abdominal disorders ZA200508341B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03010168 2003-05-06

Publications (1)

Publication Number Publication Date
ZA200508341B true ZA200508341B (en) 2007-03-28

Family

ID=34923754

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200508341A ZA200508341B (en) 2003-05-06 2005-10-14 Agents for the treatment of lower abdominal disorders

Country Status (1)

Country Link
ZA (1) ZA200508341B (en)

Similar Documents

Publication Publication Date Title
PL1660057T3 (en) Combination therapy for the treatment of ocular neovascular disorders
SI1474416T1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
IL175055A0 (en) Combinations useful for the treatment of neuronal disorders
EP1644021A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
IL173909A0 (en) Use of modified cyclosporins for the treatment of hcv disorders
AU2003286567A8 (en) Methods for the treatment of skin disorders
EP1638508A4 (en) Shunt for the treatment of glaucoma
ZA200607433B (en) Methods and compositions for the treatment of gastroin-testinal disorders
AU2003274342A8 (en) Compositions for the treatment of autoimmune disorders
IL169332A0 (en) Compounds for the treatment of metabolic disorders
AU2003228819A8 (en) Combinations for the treatment of inflammatory skin disorders
IL183656A0 (en) Indenyl derivatives and use thereof for the treatment of neurological disorders
EP1680145A4 (en) Methods and compositions for the treatment of neurological disease
EP1658072A4 (en) Compounds for the treatment of neurodegenerative disorders
EP1809265A4 (en) Methods for the treatment of synucleinopathies
IL173351A0 (en) Therapy of ocular disorders
IL178827A0 (en) Use of reboxetine for the treatment of pain
MXPA05011699A (en) Agents for the treatment of lower abdominal disorders.
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
AU2003273856A8 (en) Vr1 antagonists for the treatment of urological disorders
ZA200508341B (en) Agents for the treatment of lower abdominal disorders
HRP20041159A2 (en) Combination for the treatment of airway disorders
GB0324283D0 (en) Therapeutic agents for the treatment of bone disorders
GB0317241D0 (en) Therapeutic agents for the treatment of bone disorders